Our Team

Management Team

Click on image to see the bio

Dr. Nima Ziraknejad

PhD, PEng. CEO and Founder

More than 17 years of experience in entrepreneurship, technology innovation, and successful product commercialization in mining, oil and gas, automotive, and medical devices sectors. Since 2014, through Nima’s leadership and vision at NZTech, the Company has successfully grown from being an early-stage start-up to a profitable organization while supported by its strategic investors, a very strong medical advisory board, and reputable business and R&D partners.


Pranav Saxena

B.A.Sc. Director of Engineering

Pranav has a B.A.Sc. in engineering physics, with specialization in electrical engineering, from UBC. He has over 9 years of experience in development of embedded hardware, machine vision, and robotics for various sectors. Pranav managed the team and product design process to deploy the first devices successfully adopted by surgeons. Today, he leads the engineering team to manage NZTech’s continuing product developments.


Dr. David Fung

Ph.D. VP of Sales and Marketing

David has over 14 years of experience working with a variety of medical technologies in different capacities, focused on sales and marketing of medical devices for cardiovascular interventions, neurosurgery, orthopaedics and wound repair. He has held leadership roles in market development and channel management in the U.S., Asia Pac, and other international regions. He joined NZTech with the primary responsibility of driving the commercial growth of TIPSOTM. David completed his Ph.D. in Biomedical Engineering from Northwestern University and postdoctoral qualification from Mount Sinai School of Medicine.


Scientific Advisors

Dr. Behrang Homayoon

MD, BASc, FRCPC Medical Advisor

Dr. Behrang Homayoon graduated with distinction from the UBC department of electrical engineering, completed his medical and radiology residency training at UBC followed by fellowship training in vascular and interventional radiology at the world-renowned Miami Cardiac and Vascular Institute. He is currently the head of interventional radiology at Surrey Memorial Hospital.


Dr. David Liu

MD, FRCPC FSIR Clinical Advisor

Dr. Liu is an Interventional Radiologist and the Associate Professor of Radiology at UBC. He holds appointments at VGH, UBC Hospital, and the BC Cancer Agency. He is active in clinical research in novel embolic platforms, and cancer related thromboembolic disease.


Dr. John Chung

MD, FRCPC Clinical Advisor

Dr. Chung is an Interventional Radiologist and Clinical Instructor of Radiology at UBC. He is the director of the UBC Interventional Radiology Fellowship Program. He holds clinical appointments at VGH and UBC Hospital.


Dr. Vitor Mendes Pereira

MD, MSc Medical Advisor


Dr. Robert Beasley

MD Medical Advisor


Prof. Peter Lawrence

Scientific Advisor

Prof. Peter Lawrence is a Professor Emeritus in the UBC ECE Department with long-standing research interests and publications in human interface devices and their evaluation. He has relevant experience in image processing, eye/gaze tracker design, mobile machine hand-control design, machine motion simulators, and human coordinated control.


Business Advisors

Terry Vanderkruyk

Investor Board of Directors

Terry is an experienced executive in the life sciences sector, with a focus on business development and finance. Most recently he was part of the senior management team at Coastal Contacts, a world leading optical company that was acquired by Essilor International for $430 million. He is the President of ZT Capital Inc., which focuses on investing in early stage companies and assisting in their growth.


Dr. Shahram Tafazoli

Investor Board of Directors

Shahram has over 25 years of experience in entrepreneurship and technology innovation. Shahram is the Founder and CEO at Motion Metrics Int. with products that have revolutionized safety and productivity in mining environments.


Mark Gray

Investor Business Advisor

Mark has a keen interest in early stage growth companies. Companies he has invested in cover a broad range of technologies, including health and life sciences. Mark has an MBA from the Stanford Graduate School of Business, Class of 1980.


David Christie

Commercialization Consultant

David Christie is an experienced executive with a proven ability to commercialize innovative technology. He is the founder and current president of Christie Consulting Services, and an executive-in-residence at Wavefront AC.